Follicular lymphoma prog list

Flow
Tutorial

Myeloproliferative neoplasms	Neoplasms with eosinophilia (PDGRA/PDGFRB/FGFR1)	MDS/MPN	MDS	AML	Acute leukemia ambiguous lineage
Precursor lymphoid neoplasms	Mature B cell neoplasms	Mature T and NK neoplasms	Hodgkin lymphoma	Immunodeficiency associated lymphoproliferative disorders	Histiocytic and dendritic cell neoplasms

Follicular Lymphoma
	Unusual antigen expression abstracts	Prognostic abstracts	Cytogenetic abstracts	Antigen chart

B cell prolymphocytic leukemia

Splenic B cell marginal zone lymphoma

Hairy cell leukemia

Splenic B cell lymphoma / leukemia

Lymphoplasmacytic lymphoma

Heavy chain disease

Nodal marginal zone lymphoma

Primary cutaneous follicle center lymhoma

DLBCL associated with chronic inflammation

Lymphomatoid granulomatosis

Primary mediastinal large B cell lymphoma

Intravascular large B cell lymphoma

ALK positive large B cell lymphoma

Plasmablastic lymphoma

Large B cell lymphoma - HHV8 associated multicentric Castleman

Primary effusion lymphoma

Burkitt lymphoma

B cell lymphoma, unclassifiable with features of DLBCL and Burkitt

B cell lymphoma, unclassifiable with features of DLBCL and Hodgkin

Article	Notes
Miscellaneous studies
Immune Response Signatures
Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells.	Gene expression profiles on non-malignant immune cells
High numbers of tumor-infiltrating FOXP3-positive regulatory T cells are associated with improved overall survival in follicular lymphoma.	FoxP3 regulatory T-cells
Follicular Lymphoma International Prognostic Index (FLIPI)
Follicular lymphoma international prognostic index.	Age, stage, hemoglobin, number of nodal areas, LDH
Aggressive Disease
CD10-MUM1+ follicular lymphoma lacks BCL2 gene translocation and shows characteristic biologic and clinical features.	CD10, Mum-1, Bcl-2, Bcl-6